Trial intelligence / Profile preview

Sibutramine vs CPAP in Obese Patients With Obstructive Sleep Apnea

NCT00729963Phase 4Completed

Sponsor
Université Laval
Start
Jan 2004
Primary completion
Sep 2007
Modality
Small Molecules
01

Overview

A Phase 4 trial of sibutramine in obstructive sleep apnea (OSA), obesity, sponsored by Université Laval. Started Jan 2004; status: completed.

02

Drugs

sibutramine
03

Conditions

obstructive sleep apnea (OSA)obesity

Beyond the preview

Go deeper on NCT00729963.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00729963.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call